Cerba Healthcare, headquartered in France, is a leading player in the global healthcare sector, specialising in laboratory services and diagnostics. Founded in 1967, the company has expanded its operations across Europe, Africa, and the Middle East, establishing a strong presence in the medical testing industry. With a commitment to innovation, Cerba Healthcare offers a comprehensive range of services, including clinical pathology, genetic testing, and specialised diagnostics. Their unique approach combines advanced technology with a patient-centric focus, ensuring high-quality results and rapid turnaround times. Recognised for its excellence, Cerba Healthcare has achieved significant milestones, positioning itself as a trusted partner for healthcare professionals and institutions. The company’s dedication to precision and reliability has solidified its reputation as a leader in the laboratory services market.
How does Cerba Healthcare's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Health Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Cerba Healthcare's score of 44 is higher than 68% of the industry. This can give you a sense of how well the company is doing compared to its peers.
In 2024, Cerba Healthcare reported total carbon emissions of approximately 197,349,000 kg CO2e. This figure includes 12,756,000 kg CO2e from Scope 1 emissions, 3,208,000 kg CO2e from Scope 2 emissions, and a significant 181,835,000 kg CO2e from Scope 3 emissions. The total emissions for 2023 were about 19,011,000 kg CO2e for Scopes 1 and 2 combined, with Scope 1 emissions at 12,879,000 kg CO2e and Scope 2 emissions at 6,131,000 kg CO2e. Cerba Healthcare has set ambitious climate commitments, aiming for a 42% reduction in CO2 emissions for Scopes 1 and 2 by 2030, using 2021 as the baseline year. This target reflects a commitment to reducing emissions from their direct operations and energy consumption, aligning with industry standards for climate action. The company has demonstrated progress towards these targets, with a clear focus on reducing their carbon footprint in the healthcare sector. Their emissions data is sourced directly from Cerba HealthCare S.A.S., ensuring transparency and accountability in their climate reporting.
Access structured emissions data, company-specific emission factors, and source documents
| 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|
| Scope 1 | 7,730,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 4,091,000 | 0,000,000 | 0,000,000 | 0,000,000 |
| Scope 3 | 677,284,000 | - | - | 000,000,000 |
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Cerba Healthcare has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.

